Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Barlier

Showing results (91-100 of 166) with videos related to

Pageof 17
Sort By:
Frontiers in Oncology|October 20, 2018
Negative Survival Impact of High Radiation Doses to Neural Stem Cells Niches in an IDH-Wild-Type Glioblastoma PopulationXavier Muracciole, Wassim El-Amine, Emmeline Tabouret, et al.
Plos One|May 9, 2015
Identifying the Deleterious Effect of Rare LHX4 Allelic Variants, a Challenging IssueClaire Rochette, Nicolas Jullien, Alexandru Saveanu, et al.
Human Mutation|May 8, 2013
Simultaneous hyper- and hypomethylation at imprinted loci in a subset of patients with GNAS epimutations underlies a complex and different mechanism of multilocus methylation defect in pseudohypoparathyroidism type 1bStéphanie Maupetit-Méhouas, Salah Azzi, Virginie Steunou, et al.
The Journal of Investigative Dermatology|November 10, 2024
Deconvoluted Methylation Profiles Discriminate between Closely Related Melanocytic NeviDaniel Aldea, Nicolas Macagno, Elise Marechal, et al.
Histopathology|August 23, 2023
Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An updateThibault Kervarrec, Daniel Pissaloux, Franck Tirode, et al.
The Journal of Clinical Endocrinology and Metabolism|February 15, 2007
Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomasAnne Barlier, Jean-François Vanbellinghen, Adrian F Daly, et al.
Hormone Research in Paediatrics|April 29, 2026
Unraveling the Genetic Heterogeneity of Isolated Growth Hormone Deficiency: Insights from the GENHYPOPIT cohortKarine Aouchiche, Pauline Romanet, Théo Charnay, et al.
Endocrine-Related Cancer|June 9, 2016
In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cellsThomas Cuny, Caroline Zeiller, Martin Bidlingmaier, et al.
Cancer Research|December 17, 2008
Somatostatin receptor sst2 decreases cell viability and hormonal hypersecretion and reverses octreotide resistance of human pituitary adenomasJulie Acunzo, Sylvie Thirion, Catherine Roche, et al.
European Journal of Endocrinology|November 1, 2019
Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism?Lucie Coppin, Margaux Dufosse, Pauline Romanet, et al.
Pageof 17

Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
Frontiers in Oncology|October 20, 2018
Negative Survival Impact of High Radiation Doses to Neural Stem Cells Niches in an IDH-Wild-Type Glioblastoma PopulationXavier Muracciole, Wassim El-Amine, Emmeline Tabouret, et al.
Plos One|May 9, 2015
Identifying the Deleterious Effect of Rare LHX4 Allelic Variants, a Challenging IssueClaire Rochette, Nicolas Jullien, Alexandru Saveanu, et al.
Human Mutation|May 8, 2013
Simultaneous hyper- and hypomethylation at imprinted loci in a subset of patients with GNAS epimutations underlies a complex and different mechanism of multilocus methylation defect in pseudohypoparathyroidism type 1bStéphanie Maupetit-Méhouas, Salah Azzi, Virginie Steunou, et al.
The Journal of Investigative Dermatology|November 10, 2024
Deconvoluted Methylation Profiles Discriminate between Closely Related Melanocytic NeviDaniel Aldea, Nicolas Macagno, Elise Marechal, et al.
Histopathology|August 23, 2023
Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An updateThibault Kervarrec, Daniel Pissaloux, Franck Tirode, et al.
The Journal of Clinical Endocrinology and Metabolism|February 15, 2007
Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomasAnne Barlier, Jean-François Vanbellinghen, Adrian F Daly, et al.
Hormone Research in Paediatrics|April 29, 2026
Unraveling the Genetic Heterogeneity of Isolated Growth Hormone Deficiency: Insights from the GENHYPOPIT cohortKarine Aouchiche, Pauline Romanet, Théo Charnay, et al.
Endocrine-Related Cancer|June 9, 2016
In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cellsThomas Cuny, Caroline Zeiller, Martin Bidlingmaier, et al.
Cancer Research|December 17, 2008
Somatostatin receptor sst2 decreases cell viability and hormonal hypersecretion and reverses octreotide resistance of human pituitary adenomasJulie Acunzo, Sylvie Thirion, Catherine Roche, et al.
European Journal of Endocrinology|November 1, 2019
Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism?Lucie Coppin, Margaux Dufosse, Pauline Romanet, et al.
Pageof 17